Abstract
Cimetidine, a new H2-receptor antagonist, was safely administered to eighteen healthy man by the intravenous, intraduodenal or oral route. 2 When gastric secretion was maximally stimulated by either histamine or pentagastrin, the simultaneous administration of cimetidine produced marked inhibition of both acid and pepsin secretion. 3 Cimetidine was well absorbed by mouth and had a blood half-life of 2 hours. 4 Cimetidine was rapidly excreted via the kidneys and about 70% of the excreted material was unchanged drug. 5 Clinical evaluation of cimetidine in patients with peptic ulceration is recommended.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Black J. W., Duncan W. A., Emmett J. C., Ganellin C. R., Hesselbo T., Parsons M. E., Wyllie J. H. Metiamide--an orally active histamine H2-receptor antagonist. Agents Actions. 1973 Oct;3(3):133–137. doi: 10.1007/BF01965723. [DOI] [PubMed] [Google Scholar]
- Carter D. C., Forrest J. A., Werner M., Heading R. C., Park J., Shearman D. J. Effect of histamine H2-receptor blockade on vagally induced gastric secretion in man. Br Med J. 1974 Aug 31;3(5930):554–556. doi: 10.1136/bmj.3.5930.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Forrest J. A., Shearman D. J., Spence R., Celestin L. R. Letter: Neutropenia associated with metiamide. Lancet. 1975 Feb 15;1(7903):392–393. doi: 10.1016/s0140-6736(75)91305-7. [DOI] [PubMed] [Google Scholar]
- Mainardi M., Maxwell V., Sturdevant R. A., Isenberg J. I. Metiamide, an H2-receptor blocker, as inhibitor of basal and meal-stimulated gastric acid secretion in patients with duodenal ulcer. N Engl J Med. 1974 Aug 22;291(8):373–376. doi: 10.1056/NEJM197408222910801. [DOI] [PubMed] [Google Scholar]
- Milton-Thompson G. J., Williams J. G., Jenkins D. J., Misiewicz J. J. Inhibition of nocturnal acid secretion in duodenal ulcer by one oral dose of metiamide. Lancet. 1974 Apr 20;1(7860):693–694. doi: 10.1016/s0140-6736(74)92901-8. [DOI] [PubMed] [Google Scholar]
- Pounder R. E., Williams J. G., Milton-Thompson G. J., Misiewicz J. J. Relief of duodenal ulcer sysmptons by oral metiamide. Br Med J. 1975 May 10;2(5966):307–309. doi: 10.1136/bmj.2.5966.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thjodleifsson B., Wormsley K. G. Gastric response to metiamide. Br Med J. 1974 May 11;2(5914):304–306. doi: 10.1136/bmj.2.5914.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thompson M. H., Vanables C. W., Miller I. T., Reed J. D., Sanders D. J., Grund E. R., Blair E. L. Letter: Metiamide in Zollinger-Ellison syndrome. Lancet. 1975 Jan 4;1(7897):35–36. doi: 10.1016/s0140-6736(75)92392-2. [DOI] [PubMed] [Google Scholar]
- Vatier, Cheret A. M., Bonfils S. Le dosage automatique de l'activité protéolytique du suc gastrique. Biol Gastroenterol (Paris) 1968;1:15–29. [PubMed] [Google Scholar]
- Wyllie J. H., Ealding W. D., Hesselbo T., Plack J. W. Inhibition of gastric secretion in man by metiamide: a new, orally active histamine H 2 -receptor antagonist. Gut. 1973 May;14(5):424–424. [PubMed] [Google Scholar]